ZYNERBA PHARMACEUTICALS, INC. Proceeds from Common Stock Issued
ZYNERBA PHARMACEUTICALS, INC. reported Proceeds from Common Stock Issued of $1.83 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-08-14
- ZYNERBA PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2023-06-30 was $61.50K, a 92.92% decline year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2023-03-31 was $1.77M, a 1.31% decline year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $497.78K.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $3.40M.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2022 was $6.56M, a 84.82% decline from fiscal 2021.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2021 was $43.19M, a 36.23% increase from fiscal 2020.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2020 was $31.71M, a 32.40% decline from fiscal 2019.
- ZYNERBA PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2019 was $46.91M.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 2 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|
| 2023-06-30 | $61.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.83M 10-Q · filed 2023-08-14 | $2.33M derived: sum of 3 quarters · filed 2023-08-14 | $5.73M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2023-03-31 | $1.77M 10-Q · filed 2023-05-15 | $2.26M derived: sum of 2 quarters · filed 2023-05-15 | $5.67M derived: sum of 3 quarters · filed 2023-05-15 | $6.53M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-12-31 | $497.78K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $3.90M derived: sum of 2 quarters · filed 2023-03-28 | $4.77M derived: sum of 3 quarters · filed 2023-08-14 | $6.56M 10-K · filed 2023-03-28 | ||
| 2022-09-30 | $3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $4.27M derived: sum of 2 quarters · filed 2023-08-14 | $6.06M 10-Q · filed 2022-11-14 | $6.06M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-06-30 | $868.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.66M 10-Q · filed 2023-08-14 | $2.66M derived: sum of 3 quarters · filed 2023-08-14 | $2.66M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $1.79M 10-Q · filed 2023-05-15 | $1.79M derived: sum of 2 quarters · filed 2023-05-15 | $1.79M derived: sum of 3 quarters · filed 2023-05-15 | $1.79M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 derived: sum of 3 quarters · filed 2023-03-28 | $43.19M 10-K · filed 2023-03-28 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $43.19M 10-Q · filed 2022-11-14 | $45.13M derived: sum of 4 quarters · filed 2023-03-28 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $43.19M 10-Q · filed 2022-08-10 | $45.13M derived: sum of 3 quarters · filed 2023-03-28 | $45.13M derived: sum of 4 quarters · filed 2023-03-28 | ||
| 2021-03-31 | $43.19M 10-Q · filed 2022-05-16 | $45.13M derived: sum of 2 quarters · filed 2023-03-28 | $45.13M derived: sum of 3 quarters · filed 2023-03-28 | $73.08M derived: sum of 4 quarters · filed 2023-03-28 | ||
| 2020-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $1.94M derived: sum of 2 quarters · filed 2023-03-28 | $29.89M derived: sum of 3 quarters · filed 2023-03-28 | $31.71M 10-K · filed 2023-03-28 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $27.95M derived: sum of 2 quarters · filed 2021-11-15 | $29.77M 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $27.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $29.77M 10-Q · filed 2021-08-09 | ||||
| 2020-03-31 | $1.82M 10-Q · filed 2021-05-12 | |||||
| 2019-12-31 | $46.91M 10-K · filed 2022-03-01 | |||||
| 2017-03-31 | $54.25M 10-Q · filed 2017-05-09 | $58.96M derived: sum of 2 quarters · filed 2017-05-09 | $64.26M derived: sum of 3 quarters · filed 2017-05-09 | |||
| 2016-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $10.01M derived: sum of 2 quarters · filed 2017-03-27 | $10.00M 10-K · filed 2017-03-27 | |||
| 2016-11-11 | $4.20M 10-Q · filed 2016-11-14 | $9.50M 10-Q · filed 2016-11-14 | ||||
| 2016-09-30 | $5.30M 10-Q · filed 2016-11-14 | $5.30M 10-Q · filed 2016-11-14 | $5.29M 10-Q · filed 2016-11-14 | |||
| 2015-12-31 | -$59.30K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $42.12M 10-K · filed 2017-03-27 | ||||
| 2015-09-30 | $42.18M 10-Q · filed 2016-11-14 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | -$500.00 derived: sum of 2 quarters · filed 2017-03-27 | $1.41K 10-K · filed 2017-03-27 | |||
| 2014-09-30 | -$500.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.41K 10-Q · filed 2015-11-12 | ||||
| 2014-06-30 | $1.91K 10-Q · filed 2015-08-27 |